Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: shortness of breath, cough x5 days major surgical or invasive procedure: none history of present illness: mr. is a 48yo man with h/o asthma and htn who presents with 5 days of cough productive of yellow sputum, subjective fever and chills, and difficulty breathing at home. he used his inhaler without relief. denies nasal congestion, ha, sore throat, sinus pain. he also notes diarrhea 2-3 times per day for the last 4 days. denies brbpr, melena, abd pain, n/v. he has had decrased po intake for the last 5 days. on arrival to the er his temp was 102.4. peak flow was 150. labs showed a normal white count, and creatinine of 1.6. cxr was clear. he was given levofloxacin x 1, combivent neb x 1 and albuterol nebs x 2 with his peak flow only improving to 200. he also received tylenol for fever. blood cultures were ddrawn and are pending. ros: presently he denies cp, abd pain, n/v. he does have sob as above. he notes some weight loss and is unclear how much, although he believed he was 220 lbs and by bed scale he weighs 200 lbs. past medical history: htn asthma - never intubation, exacerbations typically only in setting of uris social history: lives at home with brother. smokes 3 cigarettes per day (prior heavy smoker), denies etoh or other drugs. family history: noncontributory physical exam: vitals: 100.6, 118/78, 87, 18, 92% ra -> 94% 2lnc, 91.6kg general: pleasant, conversant, shaking with chills, mildly increased wob but speaking in full sentences heent: perrl, no op injection, no sinus tenderness, ncat neck: no lad, supple pulmonary: poor air movement bilaterally with wheezes throughout all lung fields cardiac: rrr, s1s2, no r/g/m abdomen: soft, nt, nd, +bs, no hsm extremities: no c/c/e pertinent results: glucose-147* urea n-26* creat-1.6* sodium-136 potassium-3.2* chloride-96 total co2-26 wbc-10.3 rbc-4.93 hgb-14.9 hct-42.3 mcv-86 mch-30.3 mchc-35.3* rdw-13.6 plt count-221 - neuts-78.7* lymphs-15.2* monos-5.5 eos-0.4 basos-0.2 lactate-1.3 cxr: no acute cp process, hyperinflated lung fields and flattened diaphragms c/w copd. ekg: nsr at 100, nl axis, large peaked ps, no st changes, nl intervals, no qs. pa/lat cxr: chest, two views: cardiac size and mediastinal contours are normal and unchanged. hyperinflation with hemidiaphragmatic flattening again seen. prominent pulmonary arteries. there is no pneumothorax or pleural effusion. there is again prominence of the ascending aorta. impression: 1. no acute cardiopulmonary process; stable obstructive lung patent. 2. prominence of ascending aorta again demonstrated, for which a cta or echocardiography could be considered. echo:conclusions: the left atrium is normal in size. there is mild symmetric left ventricular hypertrophy with normal cavity size and regional/global systolic function (lvef>55%). right ventricular chamber size and free wall motion are normal. the aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic regurgitation. the mitral valve appears structurally normal with trivial mitral regurgitation. there is mild pulmonary artery systolic hypertension. there is no pericardial effusion. impression: symmetric lvh with preserved global and regional biventricular systolic function. mild pulmonary hypertension. brief hospital course: a/p: 48yo man with asthma, htn, presents with 5d of productive cough, decreased po intake, diarrhea and shortness of breath. found to have decreased peak flow, wheezing, and arf. #. hypercarbic respiratory distress: likely this is due to an asthma exacerbation in setting of uri. pt was initially treated with bipap, albuterol and ipratropium nebs were given continuously q6h, and patient was started on iv salumedrol and covered for infection with a 7 day course of levofloxacin. patient was continued on his outpt advair 500-50 twice daily. pt with hyperinflated lung fields on cxr suggesting copd component for which the patient was started on tiotropium. alpha 1 antitrypsin level returned within normal range. on day of admission, patient was able to ambulate with 02sats of 92-93 on ra. # hypertension: he is on hctz, lisinoprol and atenolol at home. lisinopril had been held in setting of arf which has now resolved and atenolol was discontinued in setting of bronchoconstriction. hydralazine 20mg iv was given for isolated episode of hypertension and emesis ensued. once arf resolved, patient was resumed on his home bp regimen. # cough: pt presented with cough and there was concern for possible pneumonia which has not blossomed on cxr, vs bronchitis. given very high temp of 102.4 in er was continued on levoquin to cover for cap. however, in absence of high fevers on the floor strong possibility that this is viral, especially in combination with pt's diarrhea. sputum culture, urine legionella antigen, and blood cultures were negative. # arf: admission high of 1.6, with improvement then increase in creatinine to 1.4 on . pt had diarrhea and had not been eating for last 3-4 days. likely this was prerenal due to dehydration. improved with continued ivf and po intake. #) prophylaxis: heparin sq, holding bowel regimen given diarrhea, no indication for ppi. #) elevated blood glucose: most likely a result of steroids and covered inpatient with insulin sliding scale. recommend further work up as an outpatient once off steroids. #) ecg changes (enlarged p wave morphology): concerning for atrial enlargement. - repeat echo with similar findings when compared to prior echo. #) fen: lytes monitored and repleted prn, regular diet maintained. #) code status: full code #) communication: patient and daughter . #) dispo: to home once ambulating off o2. medications on admission: advair 500-50 q puff (per pt uses only daily) albuterol inhaler prn lisinopril 40mg po qday hydrochlorothiazide 25mg po daily atenolol 50mg po daily discharge medications: 1. fluticasone-salmeterol 500-50 mcg/dose disk with device sig: one (1) disk with device inhalation twice a day. 2. hydrochlorothiazide 25 mg tablet sig: one (1) tablet po daily (daily). 3. nicotine 7 mg/24 hr patch 24 hr sig: one (1) patch 24 hr transdermal daily (daily). disp:*30 patch 24 hr(s)* refills:*0* 4. levofloxacin 250 mg tablet sig: one (1) tablet po q24h (every 24 hours) for 1 days. disp:*1 tablet(s)* refills:*0* 5. tiotropium bromide 18 mcg capsule, w/inhalation device sig: one (1) cap inhalation daily (daily). disp:*30 cap(s)* refills:*2* 6. lisinopril 20 mg tablet sig: one (1) tablet po daily (daily). discharge disposition: home discharge diagnosis: chronic obstructive pulmonary disease intermittent asthma hypertension discharge condition: stable, ambulating on room air with oxygen saturations of 92-93%. discharge instructions: you have been evaluated and treated for shortness of breath requiring 2 days in the icu for respiratory distress. you were treated with iv steroids, nebulizers, and levofloxacin. diagnostic testing revealed that in addition to your intermittent asthma, you may have a component of chronic obstructive pulmonary disease and have had an exacerbation requiring this hospitalization. it is recommended that you stop smoking tobacco. we have started spiriva to treat this chronic obstructive pulmonary disease in addition to your current asthma medications. it is advised that you follow up with your primary care physician before the end of this week prior to returning to work on . please call your physician or return to the emergency department if you have shortness of breath that is not relieved by your inhalers, fevers, chills, or new productive cough. followup instructions: please follow up with your primary care physician, . by calling him at to schedule an appointment by the end of this week, prior to your return to work. procedure: non-invasive mechanical ventilation diagnoses: tobacco use disorder acute kidney failure, unspecified other pulmonary insufficiency, not elsewhere classified obstructive chronic bronchitis with (acute) exacerbation other chronic pulmonary heart diseases 

Answer: The patient is high likely exposed to